Biovision World Life Science Forum 2017

Biovision World Life Science Forum 20174 - 6 April 2017, Lyon, France.
Biovision World Life Science Forum is fostering a unique approach to meet, connect and collaborate between international decision-makers from the academic, civil society, policy-making and private sectors whether industrials or investors. Biovision being the place to network and make the connections you need to secure partnerships, investments and contacts.

Presenting an impressive line-up of participants addressing evidence and research as well as development and promotion, the 2017 edition of the Biovision life sciences forum affirms its status as a standout gathering of knowledge among other such international meetings. This year, the forum will welcome major players from the health sector representing each step of the value chain (research, innovation, partnerships and finance) with the goal of arriving at concrete solutions to existing and future health issues.

Biovision Prospective: A meeting place for stakeholders in global health
The Prospective meetings will facilitate discussions between Biovision participants, international experts and leading figures in global health and prevention throughout the course of four main session focusing on the following paths:

  • Global medical education & training
  • Digital health and innovation for sustainable healthcare
  • Emerging viral diseases
  • Animal health
  • Cancer
  • Innovative technologies and science of metagenomics to reach ONE HEALTH

During each session, twenty to thirty experts will participate and exchange ideas in workshops. Their conclusions will be presented at plenary session and finalized within the Call for action addressed to the international community at Biovision's closing ceremony.

Biovision Catalyzer: A springboard for innovative health projects and start-ups
Innovators in the fields of Biotech, Medtech and e-health may hold the solutions to the health issues of today and tomorrow. Biovision is committed to discovering these individuals, supporting them by putting their ideas in the spotlight, and placing them on the fast track towards the fulfilment and realisation of their work. During the Catalyzer meetings, these pioneers in emerging health fields will have the opportunity to pitch their proposals to an expert committee comprised of academic, industry and civil society partners for the chance to develop future collaborations as well as further implementation of their projects.

Innovators will also be more than welcome to take part in Biovision Prospective paths, to challenge, exchange and discuss with Key Opinion Leaders (KOLs) and experts, participate in the ensuing Insight sessions that will lead to Call for Actions on major health issues. They will also get to meet and exchange with KOLs during 'Coffee with' sessions.

Biovision Investor: The intersection of health start-ups and venture capital
The INVESTOR accelerates the fundraising process of Biotech, Medtech and e-health start-ups by putting them in direct contact with potential business and development partners. Selected from a pool of applicants by a special committee, start-ups with the greatest potential to offer innovative health solutions will present their pitches during the Biovision forum in front of a jury comprised of leading European private and corporate investors in the life sciences.

For furher information, please visit:
http://www.biovision.org

Most Popular Now

Mental Health Mobile Apps Are Effective …

When it comes to strengthening your mental or emotional health, would you trust an app? A trio of Brigham Young University health science researchers has published new research that says...

Virtual Reality for Bacteria

Scientists at the Institute of Science and Technology Austria (IST Austria) have managed to control the behavior of individual bacteria by connecting them to a computer. The interdisciplinary team including...

Social Mobile Gaming Boosts Rehabilitati…

The researchers from Imperial have designed a video game called Balloon Buddies, which is a tool that enables those recovering from conditions such as a stroke to engage and play...

Open Call SC1-HCC-03-2018: Support to Fu…

Citizens in ageing populations wish to stay in their homes for as long as possible. They are however at risk of age related impairments such as poor health, cognitive impairment...

New Software can Verify Someone's Identi…

In the science-fiction movie Gattaca, visitors only clear security if a blood test and readout of their genetic profile matches the sample on file. Now, cheap DNA sequencers and custom...

Philips to Help Develop AI and Machine L…

Royal Philips (NYSE: PHG, AEX: PHIA), a leader in health technology, is pleased to be associated with the government's recently announced £4.7 billion Industrial Strategy Challenge Fund. Working with public...

Open Call SC1-HCC-05-2018: Support to a …

The Communication on the mid-term review of the implementation of the Digital Single Market Strategy (COM(2017)228) identified three priorities on digital transformation of health and care (DTHC): citizens' access to...

Roche to Acquire Viewics, Inc. to Provid…

Roche (SIX: RO, ROG; OTCQX: RHHBY) has announced an agreement with Viewics, Inc., a privately held software company focused on laboratory business analytics. Under the agreement, Roche is acquiring all...

Philips Expands its Radiology Solutions …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has acquired US-based start-up company Analytical Informatics, Inc., complementing its own innovation initiatives to...

Philips Expands its Population Health Ma…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has acquired VitalHealth, a leading provider of cloud-based population health management solutions for the...

West of Scotland Creates Regional Portal

Scottish health boards covering a population of 2.2 million people are able to share patient information now that a two-year project to create a regional portal has been completed. Five...